Novel compounds of the formula (I), in which D, W, X, Y, T and R
1
are as defined in Patent Claim
1
, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumours.
公式(I)的新型化合物,其中D、W、X、Y、T和R1的定义如专利权利要求书1所述,是
凝血因子Xa的
抑制剂,可用于预防和/或治疗血栓栓塞病和肿瘤的治疗。